Paul Anderson, CEO, Orthocell Ltd 00:00:00
Orthocell Ltd (ASX: OCC) managing director and CEO Paul Anderson gives Proactive an update on the company that has recently had it’s nerve repair device Remplir™ added to the Australian Prostheses list and gaining Australian reimbursement from private healthcare funds. Anderson discusses plans for expansion in the US and milestones coming up in the near future.